119th Congress
H.R. 6434
Freedom to Heal Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Madeleine Dean(D-PA)
- Introduced
- Dec 4, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on the Judiciary
- Official text
- Introduced in House · Congress.gov page
Cosponsors (18)
Original cosponsors (7)
- Dan Crenshaw (R-TX)
- Jack Bergman (R-MI)
- J. Luis Correa (D-CA)
- Morgan Luttrell (R-TX)
- Nancy Mace (R-SC)
- Ro Khanna (D-CA)
- Ted Lieu (D-CA)
Added later (11)
- Glenn Grothman (R-WI) · Dec 15, 2025
- Sarah Elfreth (D-MD) · Dec 15, 2025
- Daniel S. Goldman (D-NY) · Dec 16, 2025
- Sarah McBride (D-DE) · Dec 16, 2025
- Tony Wied (R-WI) · Jan 7, 2026
- Derrick Van Orden (R-WI) · Jan 12, 2026
- Brian K. Fitzpatrick (R-PA) · Feb 4, 2026
- Eric Sorensen (D-IL) · Feb 12, 2026
- Steve Cohen (D-TN) · Feb 23, 2026
- Julie Johnson (D-TX) · Mar 27, 2026
- Thomas R. Suozzi (D-NY) · Oct 9, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To establish a special registration under the Controlled Substances Act for schedule I eligible investigational drugs under the Federal Right to Try law.
Latest action(Dec 4, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- Dec 4, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Dec 4, 2025
Introduced in House